Form 4: Director Acquires ClearPoint Neuro Stock

Timothy T. Richards, a Director at ClearPoint Neuro, Inc., acquired 222 shares of common stock on July 1, 2026, as payment for services rendered.

Summary

• Timothy T. Richards, a Director of ClearPoint Neuro, Inc., acquired 222 shares of common stock on July 1, 2026.
• The acquisition was made under the issuer's Non-Employee Director Compensation Plan, as amended and restated, in payment of fees owed to Mr. Richards.
• The shares were issued at a price of $17.84 per share, based on the closing price of the issuer's common stock on June 30, 2026.
• Following this transaction, Mr. Richards beneficially owns 87,544 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine compensation transaction for a director rather than a significant strategic event or financial performance indicator.

Positives

• Director compensation paid in stock aligns management's interests with shareholders.
• The acquisition of shares by a director indicates continued commitment to the company.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that the use of stock as compensation for non-employee directors is a common practice in the biotechnology and medical device sectors, aligning executive incentives with long-term shareholder value.

Stakeholder Impact

• Shareholders: The issuance of stock for compensation is a standard practice that can align director interests with shareholders, but it also dilutes existing ownership slightly.

Key Dates

Keywords

ClearPoint Neuro, CLPT, Form 4, Director, Stock Acquisition, Beneficial Ownership, Compensation Plan